Choitsu Sakamoto Selected Research

loxoprofen (CS 600)

1/2021	Cost-effectiveness analysis of branded and authorized generic celecoxib for patients with chronic pain in Japan.
1/2018	Repeatability of small bowel transit time in capsule endoscopy in healthy subjects.
1/2011	Efficacy and safety of the selective cyclooxygenase-2 inhibitor celecoxib in the treatment of rheumatoid arthritis and osteoarthritis in Japan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Choitsu Sakamoto Research Topics

Disease

18	Ulcer 01/2017 - 02/2002
18	Neoplasms (Cancer) 11/2014 - 06/2002
14	Hemorrhage 01/2021 - 11/2001
12	Chronic Hepatitis C 04/2015 - 04/2012
11	Wounds and Injuries (Trauma) 01/2019 - 10/2005
9	Stomach Neoplasms (Stomach Cancer) 01/2010 - 04/2004
8	Dyspepsia (Indigestion) 01/2018 - 01/2009
8	Non-Erosive Reflux Disease 07/2015 - 01/2009
8	Infections 08/2014 - 11/2004
7	Gastritis 01/2010 - 04/2004
6	Ascites 08/2014 - 05/2002
6	Gastroesophageal Reflux (GERD) 08/2013 - 08/2004
6	Peptic Esophagitis (Reflux Esophagitis) 01/2011 - 05/2007
6	Stomach Ulcer (Gastric Ulcer) 11/2010 - 03/2004
5	Rheumatoid Arthritis 01/2021 - 10/2007
5	Fibrosis (Cirrhosis) 12/2014 - 11/2001
5	Colorectal Neoplasms (Colorectal Cancer) 11/2014 - 08/2006
5	Liver Cirrhosis (Hepatic Cirrhosis) 08/2014 - 11/2004
5	Peptic Ulcer (Peptic Ulcers) 01/2013 - 01/2006
4	Pathologic Constriction (Stenosis) 03/2016 - 05/2006
3	Pain (Aches) 09/2017 - 05/2007
3	Portal Hypertension 02/2014 - 11/2004
3	Anemia 01/2013 - 01/2010
3	Adenoma (Adenomas) 10/2011 - 03/2003
3	Carcinoma (Carcinomatosis) 01/2010 - 03/2003
3	Adenocarcinoma 06/2008 - 04/2004
2	Osteoarthritis 01/2021 - 01/2011
2	Low Back Pain (Lumbago) 01/2021 - 01/2011
2	Chronic Pancreatitis 01/2018 - 09/2017
2	Metaplasia 01/2017 - 01/2006
2	Colonic Neoplasms (Colon Cancer) 11/2014 - 01/2009
2	Sleep Wake Disorders 08/2013 - 01/2013
2	Edema (Dropsy) 05/2013 - 01/2012
2	Hepatorenal Syndrome 03/2012 - 11/2009
2	Hepatic Encephalopathy 01/2011 - 11/2004
2	Inflammation (Inflammations) 08/2010 - 08/2003
2	Crohn Disease (Crohn's Disease) 08/2007 - 05/2006
2	Carcinogenesis 08/2006 - 05/2004
2	Prostatic Neoplasms (Prostate Cancer) 04/2005 - 06/2002
1	Chronic Pain 01/2021

Drug/Important Bio-Agent (IBA)

19	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018 - 02/2003
13	Capsules (Microcapsules)IBA 01/2018 - 05/2006
12	AcidsIBA 01/2018 - 08/2004
11	Proton Pump InhibitorsIBA 01/2017 - 05/2007
10	Proteins (Proteins, Gene)FDA Link 12/2011 - 04/2004
8	Ribavirin (Virazole)FDA LinkGeneric 04/2015 - 01/2013
8	telaprevirIBA 04/2015 - 01/2014
7	Celecoxib (Celebrex)FDA Link 01/2021 - 01/2006
7	Pharmaceutical PreparationsIBA 01/2019 - 02/2002
7	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017 - 04/2004
7	InterferonsIBA 04/2015 - 04/2012
6	EnzymesIBA 01/2018 - 02/2005
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2015 - 01/2008
6	rebamipideIBA 01/2011 - 08/2005
6	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2011 - 02/2003
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2014 - 04/2004
5	Messenger RNA (mRNA)IBA 01/2009 - 08/2003
4	GhrelinIBA 01/2015 - 11/2004
3	loxoprofen (CS 600)IBA 01/2021 - 01/2011
3	Phenobarbital (Luminal)FDA Link 10/2013 - 04/2005
3	InterleukinsIBA 03/2013 - 02/2005
3	AlbuminsIBA 03/2012 - 01/2011
3	Misoprostol (Cytotec)FDA LinkGeneric 04/2010 - 03/2004
3	Prostaglandin-E SynthasesIBA 06/2009 - 02/2005
3	CD40 Ligand (CD40L)IBA 12/2008 - 01/2008
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2006 - 08/2003
3	UreaseIBA 01/2006 - 02/2005
2	Lansoprazole (Prevacid)FDA LinkGeneric 01/2018 - 12/2013
2	SteroidsIBA 01/2018 - 12/2011
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2015 - 01/2013
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2015 - 08/2014
2	Neuregulin-1 (Neuregulin 1)IBA 11/2014 - 01/2009
2	CreatinineIBA 08/2014 - 01/2011
2	Fluvastatin FDA Link 07/2014 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 03/2014 - 01/2013
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2014 - 02/2005
2	Nizatidine (Axid)FDA LinkGeneric 08/2013 - 01/2011
2	DNA (Deoxyribonucleic Acid)IBA 03/2013 - 06/2008
2	AntigensIBA 11/2012 - 08/2006
2	LigandsIBA 04/2012 - 02/2008
2	CytokinesIBA 04/2012 - 08/2003
2	TerlipressinIBA 03/2012 - 11/2009
2	Folic Acid (Vitamin M)FDA LinkGeneric 10/2011 - 03/2003
2	Omeprazole (Prilosec)FDA LinkGeneric 04/2010 - 01/2006
2	PrebioticsIBA 05/2009 - 08/2007
2	Clarithromycin (Biaxin)FDA LinkGeneric 04/2009 - 01/2006
2	histidine-rich proteinsIBA 01/2009 - 06/2006
2	ErbB Receptors (EGF Receptor)IBA 01/2009 - 01/2004
2	Diphosphonates (Bisphosphonates)IBA 01/2009 - 10/2007
2	CCR2 ReceptorsIBA 02/2008 - 01/2008
2	geranylgeranylacetone (teprenone)IBA 01/2007 - 04/2004
2	Immunoglobulin G (IgG)IBA 01/2006 - 02/2005
2	Methylene Blue (Methylthioninium Chloride)FDA Link 05/2004 - 01/2004
2	Epidermal Growth Factor (EGF)IBA 01/2004 - 08/2003
1	thienopyridineIBA 01/2018

Therapy/Procedure

30	Therapeutics 01/2018 - 11/2004
8	Surgical Portasystemic Shunt (Portosystemic Shunt) 08/2014 - 11/2001
7	Transjugular Intrahepatic Portasystemic Shunt 08/2014 - 11/2001
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2009
2	Immunotherapy 10/2013 - 11/2012